查詢結果分析
來源資料
相關文獻
- 大腸直腸癌篩選在糞便潛血反應篩檢及血清學抽血檢查 (CEA檢查) 之研究分析
- 癌胚抗原在大腸直腸癌臨床運用之現況
- 大腸直腸癌的腫瘤指標:癌胚抗原
- Using Simple Blood Test and Pathological Risk Factors in Combination to Predict Stage-II Colorectal Cancer Recurrence Risk
- 大腸直腸癌篩檢簡介
- Irinotecan (Campto[feb9])--治療大腸直腸癌的新藥
- 大腸直腸癌的流行病學特徵及可能之成因
- 大腸直腸癌症病患生活品質及其相關因素之探討
- Colonoscopic Surveillance in Asymptomatic Persons with Family History of Colorectal Cancer
- 大腸直腸癌術後肺臟轉移之手術治療
頁籤選單縮合
題名 | 大腸直腸癌篩選在糞便潛血反應篩檢及血清學抽血檢查 (CEA檢查) 之研究分析=The Study Analysis of Fecaloccult Blood Test (FOBT) and Carcinoembryonic Antigen (CEA) in Colon Cancer |
---|---|
作者 | 文士祺; 吳文童; 蔡依倫; 李彥珍; 錢尚道; Wen, Shi-chi; Wu, Wen-tung; Tsai, I-lun; Lee, Yen-chen; Chien, Shang-tao; |
期刊 | 永達學報 |
出版日期 | 20070600 |
卷期 | 8:1 2007.06[民96.06] |
頁次 | 頁55-59 |
分類號 | 416.245 |
語文 | chi |
關鍵詞 | 大腸直腸癌; 糞便潛血反應篩檢; 癌胚抗原; 醣鎖抗原; Colon cancer; Fecaloccult blood test; FOBT; Carcinoembryonic antigen; Carbohydrateantigen; |
中文摘要 | 在大腸直腸癌好發性研究中,發現東方人以上消化道癌是較好發部位,而西方人則以下消化道癌症較為常見。在臺灣罹患大腸癌症而死亡人數僅次於肺癌和肝癌,為了因應此一趨勢本研究即針對軍中袍澤為對象來作大腸癌篩檢,在本研究中共完成1741人糞便潛血篩檢,佔有效問卷63.66%,其中呈陽性反應者248人,檢測陽性率14.24%,其中1529人血清中癌胚抗原(CEA)及醣鎖抗原(CA199)濃度檢測,佔有效問卷55.93%。其中CEA濃度大於5 U/ ml為陽性者計30人,陽性率1.96%,而CA199濃度大於37 U/ ml為陽性者計5人,陽性率0.33%。 |
英文摘要 | In the study of colon cancer, the arise frequency was higher for up-alimentary canal cancer in easterner, but the arise frequency was higher for down-alimentary canal cancer in westerner. The colon cancer's arise frequency was inferior to lung and liver cancer in Taiwan. Thus, in the study, we want to build the assay for detecting colon cancer in serviceman. The result was achieved 1741 persons for fecaloccult blood test, efficacious questionnaire 63.66%, positive answer 248 persons and positive frequency 14.24%. Therein, the consistency test for carcinoembryonic antigen and carbohydrate antigen in 1529 persons, efficacious questionnaire 55.93%, carcinoembryonic antigen test positive answer have 30 persons (CEA > 5 U/ml), positive frequency 1.96% and carbohydrate antigen test positive answer have 5 persons (CA199 > 37 U/ml), positive frequency 0.33%. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。